Preclinical experiment of auxiliary partial orthotopic liver transplantation as a curative treatment for hemophilia

Liver Transplantation

Volumn 11, Issue 5, 2005, Pages 579-584

  Ko, Saiho ^a   Tanaka, Ichiro ^a   Kanehiro, Hiromichi ^a   Kanokogi, Hideki ^a   Ori, Jun Ichi ^a   Shima, Midori ^a   Yoshioka, Akira ^a   Giles, Alan ^b   Nakajima, Yoshiyuki ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BLOOD CLOTTING FACTOR 8;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLEEDING; CONTROLLED STUDY; DOG; DONOR; FEASIBILITY STUDY; HEMOPHILIA A; HEMOSTASIS; LIVER FUNCTION TEST; LIVER TRANSPLANTATION; MALE; NONHUMAN; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RECIPIENT;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; FACTOR VIII; GRAFT SURVIVAL; HEMOPHILIA A; LIVER; LIVER TRANSPLANTATION; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 18944392702     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20390     Document Type: Article

References (33)

1. Lewis JH, Bontempo FA, Spero JA, Ragni MV, Starzl TE. Liver transplantation in a hemophiliac. N Engl J Med 1985;312: 1189-1190.
2. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998;42:744-749.
3. McCarthy M, Gane E, Pereira S, Tibbs CJ, Heaton N, Rela M, et al. Liver transplantation for haemophiliacs with hepatitis C cirrhosis. Gut 1996;39:870-875.
4. Scharrer I, Encke A, Hottenrott C. Clinical cure of haemophilia A by liver transplantation. Lancet 1988;2:800-801.
5. Lerut JP, Laterre PF, Lavenne-Pardonge E, Donataccio M, Geubel A, Reynaert MS, et al. Liver transplantation and haemophilia A. J Hepatol 1995;22:583-585.
6. Delorme MA, Adams PC, Grant D, Ghent CN, Walker IR, Wall WJ. Orthotopic liver transplantation in a patient with combined hemophilia A and B. Am J Hematol 1990;33:136-138.
7. Wilde J, Teixeira P, Bramhall SR, Gunson B, Mutimer D, Mirza DF. Liver transplantation in haemophilia. Br J Haematol 2002; 117:952-956.
8. Yoshioka A, Shima M, Fukutake K, Takamatsu J, Shirahata A; Coganate FS Study Group. Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan. Haemophilia 2001;7:242-249.
9. Yoshioka A, Nishio K, Shima M. Thrombelastgram as a haemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII. Haemostasis 1996;26(Suppl 1):139-142.
10. Buffet C, Laurent-Puig P, Chandot S, Laurian Y, Charpentier B, Briantais MJ, et al. A high hepatitis E virus seroprevalence among renal transplantation and hemophila patient populations. J Hepatol 1996;24:122-125.
11. Bismuth H, Azoulay D, Samuel D, Reynes M, Grimon G, Majno P, et al. Auxiliary partial orthotopic liver transplantation for fluminant hepatitis. The Paul Brousse experience. Ann Surg 1996;224:712-724.
12. Gubernatis G, Pichlmayr R, Kemnitz J, Grats K. Auxiliary partial orthotopic liver transplantation (APOLT) for fluminant hepati failure: first successful case report. World J Surg 1991;15: 660-665.
13. Boudjema K, Cherqui D, Jaeck D, Chenard-Neu MP, Steib A, Freis G, et al. Auxiliary liver transplantation for fulminant and subfulminant hepatic failure. Transplantation 1995;59: 218-223.
14. Uemoto S, Yabe S, Inomata Y, Nishizawa H, Asonuma K, Egawa H, et al. Coexistence of a graft with the preserved native liver in auxiliary partial liver transplantation from a living donor for ornithine trascarbamylase deficiency. Transplantation 1997;63: 1026-1028.
15. Rela M, Muiesan P, Andreani P, Gibbs P, Mieli-Vergani G, Mowat AP, et al. Auxiliary liver transplantation for metabolic diseases. Transplant Proc 1997;29:444-445.
16. Kayler LK, Merion RM, Lee S, Sung RS, Punch JD, Rudich SM, et al. Long-term survival after liver transplantation in children with metabolic disorders. Pediatr Transplant 2002;6:295-300.
17. Komatsu H, Inui A, Fujisawa T, Sogo T, Miyagawa Y, Inui M, et al. Severe late acute allograft rejection in a child after living-related auxiliary partial orthotopic liver transplantation for ornithine transcarbamylase deficiency. Clin Transplant 1999;13: 300-304.
18. Broelsch CE, Emond JC, Whitington PF, Thistlethwaite JR, Baker AL, Lichtor JL. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg 1990;212:368-375.
19. Whitington PF, Emond JC, Heffron T, Thistlethwaite JR. Orthotopic auxiliary liver transplantation for Crigler-Najjjar syndrome type 1. Lancet 1993;342:779-780.
20. Ori J, Tanaka I, Kubota Y, Matsumoto T, Kamisue S, Shibata M, et al. The assessment of carrier status of canine hemophilia A in a hemophilic colony. Jpn J Thromb Hemostat 2002;13:252-258.
21. Ko S, Nakajima Y, Kanehiro H, Horikawa M, Yoshimura A, Taki J, et al. The enhanced immunosuppressive efficacy of newly developed liposomal FK506 in canine liver transplantation. Transplantation 1995;59:1384-1388.
22. Horita K, Matsunami H, Shimizu Y, Shimizu A, Kurimoto M, Suzuki K, et al. Treatment of a patient with hemophilia A and hepatitis C virus-related cirrhosis by living-related liver transplantation from an obligate carrier donor. Transplantation 2002; 73:1909-1912.
23. Sugawara Y, Ohkubo T, Makuuchi M, Kimura S, Morisawa Y, Tachikawa N, et al. Living-donor liver transplantation in an HIV-positive patient with hemophilia. Transplantation 2002; 74:1655-1656.
24. Kaibori M, Egawa H, Inomata Y, Uemoto S, Asonuma K, Kiuchi T, et al. Selective portal blood flow diversion in auxiliary partial orthotopic liver transplantation. Transplantation 1998;66:935-937.
25. Yabe S, Nishizawa H, Egawa H, Nakayama H, Okamoto S, Kiuchi T, et al. Portal blood flow and liver regeneration in auxiliary partial orthotopic liver transplantation in a canine model. Eur Surg Res 1999;31:83-92.
26. de Jonge J, Zondervan PE, IJzermans JN, Metselaar HJ, Tilanus HW. Importance of portal flow diversion in experimental auxiliary partial orthotopic liver transplantation. Transplantation 2000;70:44-47.
27. Azoulay D, Samuel D, Ichai P, Castaing D, Saliba F, Adam R, et al. Auxiliary partial orthotopic versus standard orthotopic whole liver transplantation for acute liver failure: a reappraisal from a single center by a case-control study. Ann Surg 2001;234:723-731.
28. Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, et al. Evidence for gene transfer and expression of factor XI in hemophilia B patients treated with an AAV vector. Nat Genet 2000;24:257-261.
29. Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101:2963-2972.
30. Pasi KJ. Gene therapy for haemophilia. Br J Haematol 2001;115: 744-757.
31. Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF; Factor VIII Transkaryotic Therapy Study Group. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N Engl J Med 2001;344: 1735-1742.
32. Nathwani AC, Davidoff AM, Tuddenham EG. Prospects for gene therapy of hemophilia. Haemophilia 2004;10:309-318.
33. Inomata Y, Uemoto S, Asonuma K, Egawa H. Right lobe graft in living donor liver transplantation. Transplantation 2000;69: 258-264.